Skip to search formSkip to main contentSkip to account menu

paliperidone

Known as: 9-Hydroxy-risperidone, 9 Hydroxyrisperidone, 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one 
National Institutes of Health

Related topics

Related topics

11 relations
0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]1 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]1.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega]1.75 ML paliperidone palmitate 312 MG/ML Prefilled Syringe [Invega]

Narrower (2)

Invegapaliperidone palmitate

Broader (1)

Risperidone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders Na Ye,† John L. Neumeyer,‡ Ross J… 
Review
2008
Review
2008
Annals of General Psychiatry BioMed Central Review Isotretinoin and psychopathology: a review
  • 2008
  • Corpus ID: 340358
Review
2007
Review
2007
Clinical Pharmacokinetics of Atypical Antipsychotics
In the past, the information about the dose-clinical effectiveness of typical antipsychotics was not complete and this led to the… 
Highly Cited
2005
Highly Cited
2005
RELATIONSHIP BETWEEN EXPOSURE AND NONSPECIFIC BINDING OF THIRTY-THREE CENTRAL NERVOUS SYSTEM DRUGS IN MICE
Unbound fractions in mouse brain and plasma were determined for 31 structurally diverse central nervous system (CNS) drugs and… 
Review
2005
Review
2005
Advances in analytical toxicology: the current role of liquid chromatography–mass spectrometry in drug quantification in blood and oral fluid
This paper reviews procedures for quantification of drugs in the biosamples blood, plasma, serum, or oral fluid (saliva, etc… 
Highly Cited
2002
Highly Cited
2002
Inhibition of Risperidone Metabolism by Fluoxetine in Patients With Schizophrenia: A Clinically Relevant Pharmacokinetic Drug Interaction
The effect of fluoxetine on the steady-state plasma concentrations of risperidone and its active metabolite 9-hydroxyrisperidone… 
Highly Cited
2001
Highly Cited
2001
Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone During Combined Treatment With Paroxetine
The effects of paroxetine on steady-state plasma concentrations of risperidone and its active metabolite 9-hydroxyrisperidone (9… 
Highly Cited
2000
Highly Cited
2000
Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
To evaluate the pharmacokinetic interaction between risperidone and the mood-stabilizing agents carbamazepine and valproic acid… 
Review
1994
Review
1994
Survey on the pharmacodynamics of the new antipsychotic risperidone
This review reports on the pharmacodynamics of the new antipsychotic risperidone. The primary action of risperidone is serotonin… 
Highly Cited
1993
Highly Cited
1993
Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects
The pharmacokinetics of a novel antipsychotic agent, risperidone, and the prolactin response were studied in 12 dextromethorphan… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)